☆ 4.8 Meeting Abstract

Novel tumor-targeted, engineered IL-2 variant (IL-2v)-based immunocytokines for immunotherapy of cancer.

CANCER RESEARCH (2013)

Journal

CANCER RESEARCH

Volume 73, Issue -, Pages -

Publisher

AMER ASSOC CANCER RESEARCH

DOI: 10.1158/1538-7445.TUMIMM2012-PR8

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.